Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give SU5416 to
HIV-infected patients with AIDS-related Kaposi's sarcoma (KS). SU5416 may prevent the growth
of KS tumors.